XML 40 R27.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Restructuring Plans (Tables)
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Allergan integration plan    
Restructuring charges    
Summary of charges associated with integration plan  
The following table summarizes the prior year charges associated with the Allergan acquisition integration plan:
(in millions)Three Months Ended
June 30, 2023
Six Months Ended
June 30, 2023
Cost of products sold$32 $46 
Research and development
Selling, general and administrative51 95 
Total charges$84 $142 
Other restructuring    
Restructuring charges    
Summary of cash activity in the restructuring reserve
The following table summarizes the cash activity in the restructuring reserve for the six months ended June 30, 2024:
(in millions)
Accrued balance as of December 31, 2023$196 
Restructuring charges63 
Payments and other adjustments(77)
Accrued balance as of June 30, 2024$182